FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2956827145> ?p ?o ?g. }

• W2956827145 endingPage "181.e3" @default.
• W2956827145 startingPage "174" @default.
• W2956827145 abstract "CDKN2A and CDK4 are well-established melanoma susceptibility genes, but their effect on tumor location and distribution is unknown. We used a case–case study design to assess for differences in tumor location between mutation carriers (CDKN2A = 141 patients, 348 melanomas; CDK4 = 15 patients, 54 melanomas) and noncarriers (104 patients, 157 melanomas) in US melanoma-prone families. Associations between groups were assessed with chi-square tests. Odds ratios (ORs) for tumor location were adjusted for diagnosis age, gender, and superficial spreading subtype. Models included random effects to account for within individual and family correlations. Compared with having a truncal melanoma, CDK4 (vs. noncarriers: lower extremities OR = 14.5, 95% confidence interval [CI] = 5.02–42.0, P < 0.001; upper extremities OR = 6.88, 95% CI = 2.37–19.9, P < 0.001; head and neck OR = 18.6, 95% CI = 4.04–85.2, P < 0.001) and CDKN2A (vs. noncarriers: lower extremities OR = 3.01, 95% CI = 1.56–5.82, P < 0.05; upper extremities OR = 1.91, 95% CI = 1.03–3.52, P < 0.05; head and neck OR = 5.40, 95% CI = 2.10–13.9, P < 0.001) carriers had higher odds of developing melanoma at all other sites. Similar findings were observed for analyses stratified by gender, age, and first versus subsequent melanoma diagnoses. Further studies are needed to understand the biology underlying these genotype-associated patterns of tumor development, which could provide new insights into melanoma treatment and prevention. CDKN2A and CDK4 are well-established melanoma susceptibility genes, but their effect on tumor location and distribution is unknown. We used a case–case study design to assess for differences in tumor location between mutation carriers (CDKN2A = 141 patients, 348 melanomas; CDK4 = 15 patients, 54 melanomas) and noncarriers (104 patients, 157 melanomas) in US melanoma-prone families. Associations between groups were assessed with chi-square tests. Odds ratios (ORs) for tumor location were adjusted for diagnosis age, gender, and superficial spreading subtype. Models included random effects to account for within individual and family correlations. Compared with having a truncal melanoma, CDK4 (vs. noncarriers: lower extremities OR = 14.5, 95% confidence interval [CI] = 5.02–42.0, P < 0.001; upper extremities OR = 6.88, 95% CI = 2.37–19.9, P < 0.001; head and neck OR = 18.6, 95% CI = 4.04–85.2, P < 0.001) and CDKN2A (vs. noncarriers: lower extremities OR = 3.01, 95% CI = 1.56–5.82, P < 0.05; upper extremities OR = 1.91, 95% CI = 1.03–3.52, P < 0.05; head and neck OR = 5.40, 95% CI = 2.10–13.9, P < 0.001) carriers had higher odds of developing melanoma at all other sites. Similar findings were observed for analyses stratified by gender, age, and first versus subsequent melanoma diagnoses. Further studies are needed to understand the biology underlying these genotype-associated patterns of tumor development, which could provide new insights into melanoma treatment and prevention." @default.
• W2956827145 created "2019-07-23" @default.
• W2956827145 creator A5037297600 @default.
• W2956827145 creator A5038423396 @default.
• W2956827145 creator A5052467333 @default.
• W2956827145 creator A5057142749 @default.
• W2956827145 creator A5063007431 @default.
• W2956827145 date "2020-01-01" @default.
• W2956827145 modified "2023-10-10" @default.
• W2956827145 title "Variation in Cutaneous Patterns of Melanomagenesis According to Germline CDKN2A/CDK4 Status in Melanoma-Prone Families" @default.
• W2956827145 cites W1946633045 @default.
• W2956827145 cites W1967370147 @default.
• W2956827145 cites W1971512164 @default.
• W2956827145 cites W1976768927 @default.
• W2956827145 cites W2008144998 @default.
• W2956827145 cites W2051506850 @default.
• W2956827145 cites W2076208367 @default.
• W2956827145 cites W2087791044 @default.
• W2956827145 cites W2097096041 @default.
• W2956827145 cites W2105857063 @default.
• W2956827145 cites W2120603559 @default.
• W2956827145 cites W2122038062 @default.
• W2956827145 cites W2122889044 @default.
• W2956827145 cites W2131906164 @default.
• W2956827145 cites W2135686462 @default.
• W2956827145 cites W2153105757 @default.
• W2956827145 cites W2159448053 @default.
• W2956827145 cites W2168219489 @default.
• W2956827145 cites W2262707789 @default.
• W2956827145 cites W2284331904 @default.
• W2956827145 cites W2591791922 @default.
• W2956827145 cites W2761934863 @default.
• W2956827145 cites W2773938959 @default.
• W2956827145 cites W2787607544 @default.
• W2956827145 cites W2890644375 @default.
• W2956827145 doi "https://doi.org/10.1016/j.jid.2019.06.138" @default.
• W2956827145 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6926144" @default.
• W2956827145 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31326397" @default.
• W2956827145 hasPublicationYear "2020" @default.
• W2956827145 type Work @default.
• W2956827145 sameAs 2956827145 @default.
• W2956827145 citedByCount "11" @default.
• W2956827145 countsByYear W29568271452020 @default.
• W2956827145 countsByYear W29568271452021 @default.
• W2956827145 countsByYear W29568271452022 @default.
• W2956827145 countsByYear W29568271452023 @default.
• W2956827145 crossrefType "journal-article" @default.
• W2956827145 hasAuthorship W2956827145A5037297600 @default.
• W2956827145 hasAuthorship W2956827145A5038423396 @default.
• W2956827145 hasAuthorship W2956827145A5052467333 @default.
• W2956827145 hasAuthorship W2956827145A5057142749 @default.
• W2956827145 hasAuthorship W2956827145A5063007431 @default.
• W2956827145 hasBestOaLocation W29568271451 @default.
• W2956827145 hasConcept C104317684 @default.
• W2956827145 hasConcept C121608353 @default.
• W2956827145 hasConcept C126322002 @default.
• W2956827145 hasConcept C13514818 @default.
• W2956827145 hasConcept C143998085 @default.
• W2956827145 hasConcept C156957248 @default.
• W2956827145 hasConcept C2777658100 @default.
• W2956827145 hasConcept C2780265364 @default.
• W2956827145 hasConcept C44249647 @default.
• W2956827145 hasConcept C501734568 @default.
• W2956827145 hasConcept C502942594 @default.
• W2956827145 hasConcept C54355233 @default.
• W2956827145 hasConcept C71924100 @default.
• W2956827145 hasConcept C86803240 @default.
• W2956827145 hasConceptScore W2956827145C104317684 @default.
• W2956827145 hasConceptScore W2956827145C121608353 @default.
• W2956827145 hasConceptScore W2956827145C126322002 @default.
• W2956827145 hasConceptScore W2956827145C13514818 @default.
• W2956827145 hasConceptScore W2956827145C143998085 @default.
• W2956827145 hasConceptScore W2956827145C156957248 @default.
• W2956827145 hasConceptScore W2956827145C2777658100 @default.
• W2956827145 hasConceptScore W2956827145C2780265364 @default.
• W2956827145 hasConceptScore W2956827145C44249647 @default.
• W2956827145 hasConceptScore W2956827145C501734568 @default.
• W2956827145 hasConceptScore W2956827145C502942594 @default.
• W2956827145 hasConceptScore W2956827145C54355233 @default.
• W2956827145 hasConceptScore W2956827145C71924100 @default.
• W2956827145 hasConceptScore W2956827145C86803240 @default.
• W2956827145 hasFunder F4320314936 @default.
• W2956827145 hasFunder F4320332161 @default.
• W2956827145 hasFunder F4320337351 @default.
• W2956827145 hasFunder F4320338333 @default.
• W2956827145 hasIssue "1" @default.
• W2956827145 hasLocation W29568271451 @default.
• W2956827145 hasLocation W29568271452 @default.
• W2956827145 hasLocation W29568271453 @default.
• W2956827145 hasOpenAccess W2956827145 @default.
• W2956827145 hasPrimaryLocation W29568271451 @default.
• W2956827145 hasRelatedWork W1499264168 @default.
• W2956827145 hasRelatedWork W2039092246 @default.
• W2956827145 hasRelatedWork W2065871764 @default.
• W2956827145 hasRelatedWork W2086089386 @default.
• W2956827145 hasRelatedWork W2332902495 @default.
• W2956827145 hasRelatedWork W2475009298 @default.
• W2956827145 hasRelatedWork W2727146613 @default.

• next